Internal Medicine · Ormond Beach, FL
NPI
1285608299
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
570 Memorial Cir Ste 140
Ormond Beach, FL, 32174
Phone (904) 687-1164
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,164
101 services
Medicare patients, 2024
16
Average age 68
Drug cost, 2024
$3.2M
4,256 prescriptions
Company payments, 2025
$1,481
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel A Warner was code 99214 (office e&m - established), 33 times for 14 patients. In total Daniel A Warner billed 101 services in 10 codes, and Medicare paid $6,164.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 33 | 14 | $86.80 | $2,864 |
| 99215 Office E&M - Established | Office | 17 | 12 | $115.98 | $1,972 |
By year: 2022 $22K for 682 services; 2023 $17K for 784 services; 2024 $6,164 for 101 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel A Warner prescribed most often to Medicare patients was Rosuvastatin Calcium, with 277 prescriptions and refills. In total Daniel A Warner wrote 4,256 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 277 | 340 | 35 | $1,756 |
| Valacyclovir Valacyclovir Hcl | 269 | 310 | 36 | $11K |
| Farxiga Dapagliflozin Propanediol | 216 | 228 | 32 | $118K |
| Ozempic Semaglutide | 134 | 155 | 17 | $131K |
| Dovato Dolutegravir Sodium/Lamivudine | 95 | 95 | Under 11 | $266K |
| Pantoprazole Sodium Generic | 86 | 107 | 14 | $632 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 84 | 84 | 12 | $297K |
| Acyclovir Generic | 75 | 79 | Under 11 | $541 |
| Metoprolol Succinate Generic | 69 | 92 | 12 | $424 |
| Juluca Dolutegravir/Rilpivirine | 64 | 64 | Under 11 | $221K |
| Prezcobix Darunavir/Cobicistat | 63 | 63 | Under 11 | $151K |
| Sucralfate Generic | 61 | 67 | Under 11 | $789 |
| Mirtazapine Generic | 59 | 59 | Under 11 | $736 |
| Tivicay Dolutegravir Sodium | 56 | 56 | Under 11 | $180K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 55 | 61 | Under 11 | $217K |
Brand drugs: - claims; generic drugs: 2,818 claims; opioid claims: 93.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel A Warner $1,481 ($1,481 in general payments such as food, travel and fees) from 10 companies. The largest payer was ViiV Healthcare Company with $882.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 27 | $882 |
| Merck Sharp & Dohme LLC MRK | 7 | $171 |
| Theratechnologies Inc. THTX | 6 | $155 |
| Insmed, Inc. INSM | 4 | $88.24 |
| Exact Sciences Corporation EXAS | 3 | $54.91 |
| Abbvie Inc. ABBV | 2 | $38.84 |
| EMD Serono, Inc. MRK.DE | 2 | $37.64 |
| Napo Pharmaceuticals Inc | 1 | $20.15 |
| Gilead Sciences, Inc. GILD | 1 | $19.1 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $14.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.